EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Expert Opinion on Drug Metabolism and Toxicology


 

Status
active
Indexing
Science Citation Index Expanded™, Biochemistry & Biophysics Citation Index, Chemical Abstracts (CODEN: EODMBQ), EMBASE/Excerpta, Medica, Index Medicus/Medline
Subject

Source type
Journal
Publisher
ISBN ISSN
1742-5255
E ISSN
1744-7607
First volume
1
Last volume
8+
Homepage
Description

Expert Opinion on Drug Metabolism & Toxicology  is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

  • Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data
  • Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug

The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and related professionals.



Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )